Sarcoidosis - Pipeline Insights, 2017 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Sarcoidosis - Pipeline Insights, 2017" drug pipelines to their offering.

This report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details.

This report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Sarcoidosis. This report also assesses the Sarcoidosis therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.

Scope:

  • The report provides competitive pipeline landscape of Sarcoidosis
  • The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
  • Coverage of the Sarcoidosis pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
  • The report reviews key players involved in the therapeutics development for Sarcoidosis and also provide company profiling
  • The report also gives the information of dormant and discontinued pipeline projects
  • Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
  • Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

Key Topics Covered:

  1. Sarcoidosis Overview
  2. Sarcoidosis Pipeline Therapeutics
  3. Sarcoidosis Therapeutics under Development by Companies
  4. Sarcoidosis Filed and Phase III Products
  5. Sarcoidosis Phase II Products
  6. Sarcoidosis Phase I and IND Filed Products
  7. Sarcoidosis Discovery and Pre-Clinical Stage Products
  8. Drug Candidate Profiles
  9. Sarcoidosis - Therapeutics Assessment
  10. Assessment by Monotherapy Products
  11. Assessment by Combination Products
  12. Assessment by Route of Administration
  13. Assessment by Molecule Type
  14. Sarcoidosis - Discontinued Products
  15. Sarcoidosis - Dormant Products
  16. Companies Involved in Therapeutics Development for Sarcoidosis
  17. Appendix

For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/w6mk2h/sarcoidosis

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Respiratory Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Respiratory Drugs